Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes
Clinical trial NCT03929601 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03929601
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-30
- Primary completion
- 2027-03-31
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.